Business Context and Reporting Period
This Form 8-K reports on events occurring on April 30, 2024, for WiSA Technologies, Inc. (trading symbol: WISA), a Delaware corporation. The filing details the closing of a registered direct offering and a concurrent private placement. Note: The request metadata references "Datavault AI Inc.," but the filing text explicitly identifies the registrant as WiSA Technologies, Inc.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.4 million.
- Securities Issued: 418,845 shares of Common Stock in a registered direct offering at $5.73 per share.
- Warrants Issued: Warrants exercisable for up to 418,845 shares of Common Stock at an exercise price of $5.60 per share.
- Transaction Costs: An 8.0% placement fee paid to Maxim Group LLC, plus $50,000 in reimbursed expenses.
- Liquidity Impact: The transaction provides immediate capital; specific pre-existing cash balances, debt levels, or operating margins are not disclosed in this filing.
Material Changes and Obligations
The filing discloses the entry into a Material Definitive Agreement (Securities Purchase Agreement) and a Placement Agency Agreement. Key obligations include:
- Lock-up Period: The Company is restricted from issuing additional Common Stock or convertible securities for 30 days post-closing, with a six-month restriction on Variable Rate Transactions.
- Registration Requirements: The Company must file a Form S-1 for the resale of Warrant Shares by May 30, 2024, and keep it effective until all warrants are exercised or expire.
- Stockholder Approval: A stockholder meeting must be held by September 30, 2024, to approve the "alternative cashless exercise" feature of the warrants.
Guidance, Outlook, and Risks
This filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future operational performance. The primary risks and contingencies identified are:
- Dilution: The issuance of shares and warrants increases the share count, potentially diluting existing shareholders.
- Listing Compliance: Restrictions on future issuances may be waived only if required to satisfy Nasdaq continued listing requirements.
- Warrant Exercise Terms: Warrants are immediately exercisable but include complex cashless exercise formulas contingent on stockholder approval for certain features.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-transaction to assess dilution impact.
- Confirm the status of the Form S-1 filing for warrant resale by the May 30, 2024 deadline.
- Review the Company's current cash position and burn rate to determine the runway provided by the $2.4 million in proceeds.
- Monitor the schedule for the stockholder meeting required by September 30, 2024, regarding warrant terms.
- Check for any subsequent filings regarding the use of proceeds or changes in Nasdaq listing status.